|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
EBSCO_ocn820480844 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
121206s2011 xx a ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d OCLCF
|d JBG
|d VTS
|d VLY
|d AJS
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9781608051427
|q (electronic bk.)
|
020 |
|
|
|a 1608051420
|q (electronic bk.)
|
029 |
1 |
|
|a DEBBG
|b BV041049019
|
029 |
1 |
|
|a DEBBG
|b BV043100369
|
029 |
1 |
|
|a DEBSZ
|b 421314060
|
029 |
1 |
|
|a GBVCP
|b 804178739
|
035 |
|
|
|a (OCoLC)820480844
|
050 |
|
4 |
|a RM301.25
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.19
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Miteva, Maria A.
|
245 |
1 |
0 |
|a In silico lead discovery /
|c by Maria A. Miteva.
|
260 |
|
|
|a [Place of publication not identified] :
|b Bentham eBooks,
|c [2011]
|
300 |
|
|
|a 1 online resource :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Title from PDF title page (viewed on Dec. 6, 2012).
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a 01 Title.pdf; 02 Cover Page; 03 eBooks End User License Agreement-Website; 04 Content; 05 Foreword_Grigirov; 06 Preface_Miteva; 07 Contributors_Proposal_forEbook-MariaMiteva; 08 Chapter 1 Lagorce_et al_revised 2; 09 Chapter 2 Sperandio_et al_revised 2; 10 Chapter 3 Guyon_Tuffery_corrected 2; 11 Chapter 4 Todorov_corrected 2; 12 Chapter 5 Alexov_revised 2; 13 Chapter 6 Miteva_revised 2; 14 Chapter 7 Roche-revised 2; 15 Chapter 8 Pajeva_Wiese_revised 2; 16 Chapter 9 Moro_revised 2; 17 Chapter 10 Lee; 18 Index
|
520 |
|
|
|a Computer-aided drug design and in silico screening have contributed to the discovery of several compounds that have either reached the market or entered clinical trials. In silico Lead Discovery is a compilation of the efforts of several experts on bioinformatics and drug design in developing the latest advances of in silico approaches for lead discovery. It contains an overview of structure-based, ligand-based methods and current fragment-based methods as well as examples for successful applications of such methods in discovering new hit/lead molecules for important therapeutic targets. Treat.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Drug development.
|
650 |
|
0 |
|a Drug development
|x Computer simulation.
|
650 |
|
6 |
|a Médicaments
|x Développement.
|
650 |
|
6 |
|a Médicaments
|x Développement
|x Simulation par ordinateur.
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a Drug development
|2 fast
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500641
|z Texto completo
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 500641
|
994 |
|
|
|a 92
|b IZTAP
|